This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

The X-Change Corporation Announces The Sacred Cow Production Presentation Of 'AMERICAN DRUG WAR 2: Cannabis Destiny,' A Film By Kevin Booth

Stocks in this article: XCHC

DALLAS, April 16, 2013 /PRNewswire/ -- X-Change Corp. (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health and wellness solutions through its Phytiva Brand product lines, is excited to announce that 'AMERICAN DRUG WAR 2: Cannabis Destiny,' a film by Kevin Booth and produced by Sacred Cow Productions, will have its national release on June 6, 2013 in Denver, Colorado.  There will be a VIP screening event on Thursday, April 18, at Casselman's in Denver, Colorado to kick off the 'High Times' Cannabis Cup weekend.  The event also includes a Cloverleaf University Class taught by Ed Rosenthal as well as musical performance.

During the pre-production and research phase for 'AMERICAN DRUG WAR 2: Cannabis Destiny,' award-winning filmmaker Kevin Booth searched for a leading voice to shed light on medical cannabinoid formulations to help inform the general public.  The first installment of 'American Drug War' had premiered on Showtime in 2008 and featured interviews with University of Colorado Professor Robert Melamede, PhD, who has been working on FDA-track cannabinoid medicines through a publicly traded company, Cannabis Science, Inc., after decades of activism and scientific research.  Dr. Melamede continues his efforts to bring the actual cannabis plant derivative into the modern pharmacopeia and is again featured in the new film.

X-Change Corporation is picking up this film awareness effort and other projects that Cannabis Science had begun over the last twelve months, as Cannabis Science's sole direction has evolved to cannabinoid drug development, clinical trials, and FDA and other regulatory approval for its drugs, including its CS_TATI-1 formulation to treat Kaposi's Sarcoma. 

X-Change Corporation is also in the process of updating its website with actual testimonials and photographs of the profound efficacy of treating skin cancer and other critical ailments with topical and ingested cannabis extracts.  The precise launch date of the website with this information will be announced soon.

1 of 4

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs